← Evidence map

ArticleTranslational breast cancer research : a journal focusing on translational research in breast cancer2024

Tislelizumab: an effective treatment option for early-stage triple-negative breast cancer.

Zhigang YuPubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

Not cited yet

Full record →Abstract, authors, funding and every citing paper · PMID 38751685